Acute renal failure and intravenous immune globulin: Sucrose nephropathy in disguise?

American Journal of Therapeutics

Volumn 5, Issue 6, 1998, Pages 399-403

  Perazella, Mark A ^a   Cayco, Antonio V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; Immunoglobulin therapy; IVIG; Sucrose nephropathy

Indexed keywords

BIOTRANSFUSION; IMMUNOGLOBULIN; IMMUNOGLOBULIN CTS; IMMUNOGLOBULIN G; SUCROSE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; PRIORITY JOURNAL;

EID: 0031766207     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199811000-00008     Document Type: Article

References (29)

1. ASHP Commission on Therapeutics: ASHP therapeutic guidelines for intravenous immune globulin. Clin Pharm 1992;11:117-136.
2. Duhem C, Dicato M, Ries F: Side effects of intravenous immune globulins. Clin Exp Immunol 1994;97(Suppl 1): 79-83. immune globulins. Clin Exp Immunol 1994;97 (Suppl 1):79-83.
3. Duhem C, Dicato M, Ries F: Side effects of intravenous immune globulins. Clin Exp Immunol 1994;97(Suppl 1): 79-83. immune globulins. Clin Exp Immunol 1994;97 (Suppl 1):79-83.
4. Barton J, Herrera G, Galla J, et al: Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 1987;82:624-629.
5. Schifferli J, Leske M, Favre H, et al: High dose intravenous IgG treatment and renal function. Lancet 1991;337: 457-458.
6. Rault R, Piraino B, Johnston J, et al: Pulmonary and renal toxicity of intravenous immunoglobulin. Clin Nephrol 1991;36:83-86.
7. Ellie E, Combe C, Ferrer X: High-dose intravenous immune globulin and acute renal failure. N Engl J Med 1992;327:1032-1033.
8. Stewart R, Winney R, Cash J: Renal toxicity of intravenous immunoglobulin. Vox Sang 1993;65:244.
9. Ruggeri M, Castaman G, de Narde G, et al: Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura. Haematologica 1993;78:338-339.
10. Pasatiempo A, Kroser J, Ruducek M, et al: Acute renal failure after intravenous immunoglobulin therapy. J Rheumatol 1994;21:347-349.
11. Ahsan N, Palmer B, Wheeler D, et al: Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 1994;154:1985-1987.
12. Cantu T, Hoehn-Saric E, Burgess K, et al: Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 1995;25:228-234.
13. Poullin P, Moulen B, Ollier J, et al: Hyperoncotic renal failure after intravenous immunoglobulin therapy. Presse Med 1995;24:441-444.
14. Arunabh S, Kuman G, Avila V: Acute renal failure induced by intravenous immune globulin. American Family Physician 1996;53:862-863.
15. Corvetta A, Della Bitta R, Gabriella A, et al: Use of high dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases. Clin Exp Rheumatol 1989;7:295-299.
16. Rostoker G, Philippon C, Belghitti D, et al: Intravenous IgG for glomerulonephritis and renal function. Lancet 1991;338:544-555.
17. Kobosko J, Nicol P: Renal toxicity of intravenous immunoglobulin. Clin Nephrol 1992;37:216-217.
18. Phillips AO: Renal failure and intravenous immunoglobulin. Clin Nephrol 1992;37:217.
19. Donatini B: Transient renal dysfunction in diabetic patients after IVIG therapy. J Int Med 1992;232:376.
20. Tan E, Hajinazarian M, Bay W, et al: Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993;50:137-139.
21. Winward DB, Brophy MT: Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report. Pharmacotherapy 1995;15: 765-772.
22. Hansen-Schmidt S, Silomon J, Keller F: Osmotic nephrosis due to high dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis 1996;28: 451-453.
23. Friedman KD, Saddler MC, Tarnover AC, et al: Transient renal failure in a patient with idiopathic thrombocytopenic purpura after treatment with concomitant protein-A immunosorption and intravenous immune globulin. Blood 1992;80(suppl 1):483a.
24. Anderson W, Bethea W: Renal lesions following administration of hypertonic solutions of sucrose. JAMA 1940; 114:1983-1987.
25. Lindberg H, Wald M: Renal changes following the administration of hypertonic solutions. Arch Intern Med 1939;63:907-918.
26. Rigdon RH, Cardwell ES: Renal lesions following the intravenous injection of hypertonic solution of sucrose: a clinical and experimental study. Arch Intern Med 1942; 69:670-690.
27. DiScala V, Mautner W, Cohen J, et al: tubular alterations produced by osmotic diuresis with mannitol. Ann Intern Med 1965;63:767-775.
28. Morgan T, Little J, Evans W: Acute renal failure associated with low-molecular weight dextran infusion. Br Med J 1966;2:737-739.
29. Schwartz SL, Johnson CB: Pinocytosis as cause of sucrose nephrosis. Nephron 1971;8:246-254.